Search results
Pages
-
- Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening setting
-
- The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours
-
- Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma
-
- MLH1 promotor hypermethylation in colorectal and endometrial carcinomas from patients with Lynch syndrome
-
- Standardised training for endoscopic mucosal resection of large non-pedunculated colorectal polyps to reduce recurrence (*STAR-LNPCP study)
-
- Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
-
- Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance
-
- Psychosocial issues of individuals undergoing surveillance for increased risk of melanoma and pancreatic cancer due to a germline CDKN2A variant
-
- Socio-demographic and cultural factors related to non- participation in the Dutch colorectal cancer screening programme
-
- Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme
-
- Personalized endoscopic surveillance and intervention protocols for patients with familial adenomatous polyposis
-
- Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT)
-
- Prevalence of sarcopenia and impact on survival in patients with metastatic gastroenteropancreatic neuroendocrine tumours
-
- Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma